Medical Oxygen Concentrators Market Size, Share, and Trends 2024 to 2034

The global medical oxygen concentrators market size was USD 1.48 billion in 2023, calculated at USD 1.57 billion in 2024 and is projected to surpass around USD 2.82 billion by 2034, expanding at a CAGR of 6% from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 1198
  • Category : Healthcare

Medical Oxygen Concentrators Market

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Oxygen Concentrators Market 

5.1. COVID-19 Landscape: Medical Oxygen Concentrators Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Oxygen Concentrators Market, By Technology

8.1. Medical Oxygen Concentrators Market Revenue and Volume, by Technology, 2024-2034

8.1.1 Pulse Dose

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Continuous Flow

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Others

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Medical Oxygen Concentrators Market, By Product

9.1. Medical Oxygen Concentrators Market Revenue and Volume, by Product, 2024-2034

9.1.1. Fixed

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Portable

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Medical Oxygen Concentrators Market, By Application 

10.1. Medical Oxygen Concentrators Market Revenue and Volume, by Application, 2024-2034

10.1.1. Non-home Care

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Home Care

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Medical Oxygen Concentrators Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.1.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.1.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.1.4.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.1.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.1.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.2.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.2.4.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.2.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.2.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.2.7.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.3.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.3.4.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.3.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.3.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.3.7.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.4.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.4.4.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.4.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.4.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.4.7.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.5.4.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.5.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)

11.5.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)

11.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)

Chapter 12. Company Profiles

12.1. Teijen

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. DeVilbiss Healthcare

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. AirSep

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Inogen

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Nidek Medical

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Invacare

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. O2 Concepts

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Inova Labs

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Covidien

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Philips Respironics

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

 

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client